These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

514 related items for PubMed ID: 16495265

  • 1. Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro.
    Martinez LR, Casadevall A.
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1021-33. PubMed ID: 16495265
    [Abstract] [Full Text] [Related]

  • 2. Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin.
    van Duin D, Casadevall A, Nosanchuk JD.
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3394-400. PubMed ID: 12384341
    [Abstract] [Full Text] [Related]

  • 3. Specific antibody to Cryptococcus neoformans glucurunoxylomannan antagonizes antifungal drug action against cryptococcal biofilms in vitro.
    Martinez LR, Christaki E, Casadevall A.
    J Infect Dis; 2006 Jul 15; 194(2):261-6. PubMed ID: 16779734
    [Abstract] [Full Text] [Related]

  • 4. Temperature affects the susceptibility of Cryptococcus neoformans biofilms to antifungal agents.
    Pettit RK, Repp KK, Hazen KC.
    Med Mycol; 2010 Mar 15; 48(2):421-6. PubMed ID: 19637092
    [Abstract] [Full Text] [Related]

  • 5. Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro.
    Franzot SP, Casadevall A.
    Antimicrob Agents Chemother; 1997 Feb 15; 41(2):331-6. PubMed ID: 9021188
    [Abstract] [Full Text] [Related]

  • 6. Correlation of Neo-Sensitabs tablet diffusion assay results on three different agar media with CLSI broth microdilution M27-A2 and disk diffusion M44-A results for testing susceptibilities of Candida spp. and Cryptococcus neoformans to amphotericin B, caspofungin, fluconazole, itraconazole, and voriconazole.
    Espinel-Ingroff A, Canton E, Gibbs D, Wang A.
    J Clin Microbiol; 2007 Mar 15; 45(3):858-64. PubMed ID: 17215342
    [Abstract] [Full Text] [Related]

  • 7. In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile and planktonic clinical Candida albicans isolates.
    Shuford JA, Piper KE, Steckelberg JM, Patel R.
    Diagn Microbiol Infect Dis; 2007 Mar 15; 57(3):277-81. PubMed ID: 17141454
    [Abstract] [Full Text] [Related]

  • 8. Cryptococcus neoformans cells in biofilms are less susceptible than planktonic cells to antimicrobial molecules produced by the innate immune system.
    Martinez LR, Casadevall A.
    Infect Immun; 2006 Nov 15; 74(11):6118-23. PubMed ID: 17057089
    [Abstract] [Full Text] [Related]

  • 9. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins.
    Kuhn DM, George T, Chandra J, Mukherjee PK, Ghannoum MA.
    Antimicrob Agents Chemother; 2002 Jun 15; 46(6):1773-80. PubMed ID: 12019089
    [Abstract] [Full Text] [Related]

  • 10. Interaction of the echinocandin caspofungin with amphotericin B or voriconazole against Aspergillus biofilms in vitro.
    Liu W, Li L, Sun Y, Chen W, Wan Z, Li R, Liu W.
    Antimicrob Agents Chemother; 2012 Dec 15; 56(12):6414-6. PubMed ID: 23027186
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of Mycograb, amphotericin B, caspofungin, and fluconazole in combination against Cryptococcus neoformans by checkerboard and time-kill methodologies.
    Nooney L, Matthews RC, Burnie JP.
    Diagn Microbiol Infect Dis; 2005 Jan 15; 51(1):19-29. PubMed ID: 15629225
    [Abstract] [Full Text] [Related]

  • 12. Darunavir inhibits Cryptococcus neoformans/Cryptococcus gattii species complex growth and increases the susceptibility of biofilms to antifungal drugs.
    Brilhante RSN, Silva JAT, Araújo GDS, Pereira VS, Gotay WJP, Oliveira JS, Guedes GMM, Pereira-Neto WA, Castelo-Branco DSCM, Cordeiro RA, Sidrim JJC, Rocha MFG.
    J Med Microbiol; 2020 Jun 15; 69(6):830-837. PubMed ID: 32459616
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of amphotericin B, fluconazole and voriconazole against 162 Cryptococcus neoformans isolates from Africa and Cambodia.
    Chandenier J, Adou-Bryn KD, Douchet C, Sar B, Kombila M, Swinne D, Thérizol-Ferly M, Buisson Y, Richard-Lenoble D.
    Eur J Clin Microbiol Infect Dis; 2004 Jun 15; 23(6):506-8. PubMed ID: 15141336
    [Abstract] [Full Text] [Related]

  • 14. Voriconazole inhibits melanization in Cryptococcus neoformans.
    Martinez LR, Ntiamoah P, Gácser A, Casadevall A, Nosanchuk JD.
    Antimicrob Agents Chemother; 2007 Dec 15; 51(12):4396-400. PubMed ID: 17923488
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of heat-shock protein 90 enhances the susceptibility to antifungals and reduces the virulence of Cryptococcus neoformans/Cryptococcus gattii species complex.
    Cordeiro RA, Evangelista AJJ, Serpa R, Marques FJF, Melo CVS, Oliveira JS, Franco JDS, Alencar LP, Bandeira TJPG, Brilhante RSN, Sidrim JJC, Rocha MFG.
    Microbiology (Reading); 2016 Feb 15; 162(2):309-317. PubMed ID: 26645478
    [Abstract] [Full Text] [Related]

  • 16. A novel assay of biofilm antifungal activity reveals that amphotericin B and caspofungin lyse Candida albicans cells in biofilms.
    DiDone L, Oga D, Krysan DJ.
    Yeast; 2011 Aug 15; 28(8):561-8. PubMed ID: 21674619
    [Abstract] [Full Text] [Related]

  • 17. Antifungal susceptibilities of clinical and environmental isolates of Cryptococcus neoformans in Goiânia city, Goiás, Brazil.
    Souza LK, Fernandes Ode F, Kobayashi CC, Passos XS, Costa CR, Lemos JA, Souza-Júnior AH, Silva Mdo R.
    Rev Inst Med Trop Sao Paulo; 2005 Aug 15; 47(5):253-6. PubMed ID: 16302107
    [Abstract] [Full Text] [Related]

  • 18. Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms.
    Mowat E, Lang S, Williams C, McCulloch E, Jones B, Ramage G.
    J Antimicrob Chemother; 2008 Dec 15; 62(6):1281-4. PubMed ID: 18819968
    [Abstract] [Full Text] [Related]

  • 19. Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A.
    Shinde RB, Chauhan NM, Raut JS, Karuppayil SM.
    Ann Clin Microbiol Antimicrob; 2012 Oct 04; 11():27. PubMed ID: 23035934
    [Abstract] [Full Text] [Related]

  • 20. Cryptococcus neoformans biofilm formation depends on surface support and carbon source and reduces fungal cell susceptibility to heat, cold, and UV light.
    Martinez LR, Casadevall A.
    Appl Environ Microbiol; 2007 Jul 04; 73(14):4592-601. PubMed ID: 17513597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.